IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KARLA ALEXANDRA CERVANTES

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1386206977
CMS profile
10497147
Location
LUBBOCK, TX

General Payments · PY2021–2024

$1,439.26

  • Reported across 57 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,247.51

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nurse Practitioner TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,247.51 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $245.07 14
Phathom Pharmaceuticals, Inc. $184.70 6
QOL Medical, LLC $110.35 4
Regeneron Healthcare Solutions, Inc. $101.87 5
GENZYME CORPORATION $101.29 2
Janssen Scientific Affairs, LLC $100.62 1
Takeda Pharmaceuticals U.S.A., Inc. $85.53 4
PFIZER INC. $50.98 3
Daiichi Sankyo Inc. $49.74 2
Janssen Biotech, Inc. $39.42 2
Madrigal Pharmaceuticals $39.00 2
Ipsen Biopharmaceuticals, Inc $35.15 2
Merck Sharp & Dohme Corporation $27.22 1
Abbott Laboratories $16.46 1
INTERCEPT PHARMACEUTICALS, INC. $15.77 1
Lilly USA, LLC $15.75 1
Ardelyx, Inc. $14.71 1
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.88 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $94.66 2
PY2022 $24.88 1
PY2023 $72.21 1
PY2024 $1,247.51 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.46 06/28/2024 Food and Beverage Undisputed 01/23/2026 1125038472 CMS
ABBVIE INC. $19.31 04/18/2024 Food and Beverage Undisputed 01/23/2026 1106897718 CMS
ABBVIE INC. $9.93 04/19/2024 Food and Beverage Undisputed 01/23/2026 1106897720 CMS
ABBVIE INC. $29.65 05/29/2024 Food and Beverage Undisputed 01/23/2026 1106897722 CMS
ABBVIE INC. $1.06 05/30/2024 Food and Beverage Undisputed 01/23/2026 1106897724 CMS
ABBVIE INC. $21.58 06/26/2024 Food and Beverage Undisputed 01/23/2026 1106897726 CMS
ABBVIE INC. $20.81 07/17/2024 Food and Beverage Undisputed 01/23/2026 1106897728 CMS
ABBVIE INC. $31.43 07/30/2024 Food and Beverage Undisputed 01/23/2026 1106897730 CMS
ABBVIE INC. $11.45 08/02/2024 Food and Beverage Undisputed 01/23/2026 1106897732 CMS
ABBVIE INC. $22.19 08/28/2024 Food and Beverage Undisputed 01/23/2026 1106897734 CMS
ABBVIE INC. $27.60 10/09/2024 Food and Beverage Undisputed 01/23/2026 1106897736 CMS
ABBVIE INC. $18.53 10/14/2024 Food and Beverage Undisputed 01/23/2026 1106897738 CMS
ABBVIE INC. $17.00 10/16/2024 Food and Beverage Undisputed 01/23/2026 1106897740 CMS
ABBVIE INC. $3.62 10/16/2024 Food and Beverage Undisputed 01/23/2026 1106897742 CMS
ABBVIE INC. $10.91 11/13/2024 Food and Beverage Undisputed 01/23/2026 1106897744 CMS
Ardelyx, Inc. $14.71 04/02/2024 Food and Beverage Undisputed 01/23/2026 1146721379 CMS
Daiichi Sankyo Inc. $23.42 03/11/2024 Food and Beverage Undisputed 01/23/2026 1089407092 CMS
Daiichi Sankyo Inc. $26.32 09/16/2024 Food and Beverage Undisputed 01/23/2026 1089407090 CMS
GENZYME CORPORATION $24.00 09/13/2024 Food and Beverage Undisputed 01/23/2026 1139838151 CMS
GENZYME CORPORATION $77.29 11/19/2024 Food and Beverage Undisputed 01/23/2026 1139838161 CMS
Intercept Pharmaceuticals, Inc. $15.77 08/14/2024 Food and Beverage Undisputed 01/23/2026 1113650493 CMS
Ipsen Biopharmaceuticals, Inc $15.96 04/22/2024 Food and Beverage Undisputed 01/23/2026 1091979202 CMS
Ipsen Biopharmaceuticals, Inc $19.19 08/26/2024 Food and Beverage Undisputed 01/23/2026 1091979204 CMS
Janssen Biotech, Inc. $20.40 06/04/2024 Food and Beverage Undisputed 01/23/2026 1078739640 CMS
Janssen Biotech, Inc. $19.02 11/20/2024 Food and Beverage Undisputed 01/23/2026 1078738336 CMS
Janssen Scientific Affairs, LLC $100.62 09/10/2024 Food and Beverage Undisputed 01/23/2026 1078860403 CMS
Lilly USA, LLC $15.75 08/22/2024 Food and Beverage Undisputed 01/23/2026 1135648711 CMS
Madrigal Pharmaceuticals $19.22 09/23/2024 Food and Beverage Undisputed 01/23/2026 1144188730 CMS
Madrigal Pharmaceuticals $19.78 11/26/2024 Food and Beverage Undisputed 01/23/2026 1144188732 CMS
Merck Sharp & Dohme LLC $27.22 06/06/2024 Food and Beverage Undisputed 01/23/2026 1141741202 CMS
PFIZER INC. $19.97 05/09/2024 Food and Beverage Undisputed 01/23/2026 1131710939 CMS
PFIZER INC. $16.01 10/28/2024 Food and Beverage Undisputed 01/23/2026 1130876950 CMS
PFIZER INC. $15.00 12/11/2024 Food and Beverage Undisputed 01/23/2026 1131224246 CMS
Phathom Pharmaceuticals, Inc. $15.34 03/21/2024 Food and Beverage Undisputed 01/23/2026 1151154543 CMS
Phathom Pharmaceuticals, Inc. $113.56 03/28/2024 Food and Beverage Undisputed 01/23/2026 1151154545 CMS
Phathom Pharmaceuticals, Inc. $8.62 03/28/2024 Food and Beverage Undisputed 01/23/2026 1151154547 CMS
Phathom Pharmaceuticals, Inc. $8.22 05/20/2024 Food and Beverage Undisputed 01/23/2026 1151154549 CMS
Phathom Pharmaceuticals, Inc. $22.23 06/03/2024 Food and Beverage Undisputed 01/23/2026 1151154551 CMS
Phathom Pharmaceuticals, Inc. $16.73 11/11/2024 Food and Beverage Undisputed 01/23/2026 1151154553 CMS
QOL Medical, LLC $26.94 03/20/2024 Food and Beverage Undisputed 01/23/2026 1147737646 CMS
QOL Medical, LLC $21.93 06/19/2024 Food and Beverage Undisputed 01/23/2026 1147737648 CMS
QOL Medical, LLC $30.73 09/25/2024 Food and Beverage Undisputed 01/23/2026 1147737650 CMS
QOL Medical, LLC $30.75 11/20/2024 Food and Beverage Undisputed 01/23/2026 1147737652 CMS
Regeneron Healthcare Solutions, Inc. $13.71 04/04/2024 Food and Beverage Undisputed 01/23/2026 1114282667 CMS
Regeneron Healthcare Solutions, Inc. $27.36 05/02/2024 Food and Beverage Undisputed 01/23/2026 1114282669 CMS
Regeneron Healthcare Solutions, Inc. $20.99 07/11/2024 Food and Beverage Undisputed 01/23/2026 1114282671 CMS
Regeneron Healthcare Solutions, Inc. $22.62 08/29/2024 Food and Beverage Undisputed 01/23/2026 1114282673 CMS
Regeneron Healthcare Solutions, Inc. $17.19 12/09/2024 Food and Beverage Undisputed 01/23/2026 1114282675 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.88 06/06/2024 Food and Beverage Undisputed 01/23/2026 1153649350 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.04 05/15/2024 Food and Beverage Undisputed 01/23/2026 1137724154 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.50 08/13/2024 Food and Beverage Undisputed 01/23/2026 1137724156 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.84 11/13/2024 Food and Beverage Undisputed 01/23/2026 1137724158 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.15 12/05/2024 Food and Beverage Undisputed 01/23/2026 1137724160 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.